本页面由Tiger Trade Technology Pte. Ltd.提供服务

阿尔尼拉姆制药公司

236.01
-0.2100-0.09%
盘后236.500.4900+0.21%19:30 EDT
成交量:213.72万
成交额:5.01亿
市值:314.90亿
市盈率:42.00
高:237.91
开:235.83
低:228.59
收:236.22
52周最高:495.55
52周最低:197.81
股本:1.33亿
流通股本:1.33亿
量比:1.24
换手率:1.61%
股息:- -
股息率:- -
每股收益(TTM):5.62
每股收益(LYR):2.33
净资产收益率:96.55%
总资产收益率:12.34%
市净率:23.26
市盈率(LYR):101.29

数据加载中...

2026/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

重要事件披露

Form 8-K - Current report
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]